Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-03 Sale |
2021-05-05 4:09 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $46.09 | $368,743 | 193,752 (Direct) |
View |
| 2021-04-19 Sale |
2021-04-21 4:30 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $46.1 | $322,694 | 46,000 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-14 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
14,700 | $43.84 | $644,411 | 29,150 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-06 06:00 am |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $45.57 | $364,572 | 2,354 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $44.04 | $352,307 | 10,354 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
524 | $48.87 | $25,608 | 67,516 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
508 | $48.87 | $24,826 | 388,987 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
132 | $48.87 | $6,451 | 98,286 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $45.23 | $361,872 | 18,354 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $50.29 | $352,039 | 43,850 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 4:10 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $56.45 | $1,072,497 | 26,354 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 4:15 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $60.9 | $1,157,142 | 45,354 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
15,000 | $64.8 | $971,987 | 64,354 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 4:10 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
23,315 | $57.64 | $1,343,926 | 79,354 (Direct) |
View |
| 2020-10-09 Sale |
2020-10-13 4:20 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
23,541 | $53.57 | $1,261,069 | 0 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-05 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
125,000 | $51.6 | $6,450,484 | 102,669 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
3,000 | $50.01 | $150,036 | 54,048 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-10 8:29 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
9,000 | $46.23 | $416,055 | 110,056 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $0 | 193,752 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
5,646 | $3.95 | 193,752 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
2,354 | $1.89 | 193,752 (Direct) |
View |
| 2021-04-19 Exercise |
2021-04-21 4:30 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $0 | 46,000 (Direct) |
View |
| 2021-04-19 Exercise |
2021-04-21 4:30 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $3.95 | 46,000 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:00 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
14,700 | $0 | 29,150 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-14 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
14,700 | $3.95 | 29,150 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-06 06:00 am |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $0 | 2,354 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-06 06:00 am |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $1.89 | 2,354 (Direct) |
View |
Ownership |
2021-04-02 5:58 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Regulatory & Quality |
0 | $0 | 164,725 (Direct) |
View |
Ownership |
2021-04-02 5:56 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
0 | $0 | 215,692 (Direct) |
View |
| 2021-03-18 Tax Withholding |
2021-03-22 5:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
700 | $42.39 | 40,695 (Direct) |
View |
| 2021-03-18 Tax Withholding |
2021-03-22 5:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
2,450 | $43.19 | 40,695 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $0 | 10,354 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $1.89 | 10,354 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 7:00 pm |
N/A 2031-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
61,000 | $0 | 67,516 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 7:00 pm |
N/A 2031-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
61,000 | $0 | 388,987 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 7:00 pm |
N/A 2031-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
61,000 | $0 | 98,286 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 6:08 pm |
N/A 2031-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
210,000 | $0 | 210,000 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $0 | 18,354 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
8,000 | $1.89 | 18,354 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:00 pm |
N/A 2029-03-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
1,078 | $0 | 439,580 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
1,078 | $25.4 | 439,580 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:00 pm |
N/A 2031-01-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
1,563 | $31.99 | 1,563 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:00 pm |
N/A 2031-01-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
1,563 | $31.99 | 1,563 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 4:00 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $0 | 43,850 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
7,000 | $3.95 | 43,850 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:00 pm |
N/A 2031-01-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
1,563 | $31.99 | 1,563 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 4:10 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $0 | 26,354 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 4:10 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $1.89 | 26,354 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 4:10 pm |
N/A 2029-10-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
207 | $0 | 184,514 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 4:10 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
207 | $34.43 | 184,514 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:15 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $0 | 45,354 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 4:15 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
19,000 | $1.89 | 45,354 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:31 pm |
N/A 2029-10-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,697 | $0 | 184,514 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:31 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,697 | $34.43 | 184,514 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
15,000 | $0 | 64,354 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
15,000 | $1.89 | 64,354 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 4:10 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
23,315 | $0 | 79,354 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 4:10 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
23,315 | $1.89 | 79,354 (Direct) |
View |
| 2020-10-09 Exercise |
2020-10-13 4:20 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
23,541 | $0 | 0 (Direct) |
View |
| 2020-10-09 Exercise |
2020-10-13 4:20 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
23,541 | $1.89 | 0 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-06 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,632 | $51.15 | 34,128 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
125,000 | $0 | 102,669 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director |
125,000 | $1.89 | 102,669 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
3,000 | $0 | 54,048 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
3,000 | $1.89 | 54,048 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 8:29 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
9,000 | $0 | 110,056 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 8:29 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
9,000 | $1.89 | 110,056 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-24 4:00 pm |
N/A 2029-03-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
187 | $0 | 439,580 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-24 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
187 | $25.4 | 439,580 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
9,029 | $0 | 328,495 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
9,029 | $1.89 | 328,495 (Direct) |
View |
| 2020-07-22 Exercise |
2020-07-24 4:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
130,000 | $0 | 328,495 (Direct) |
View |
| 2020-07-22 Exercise |
2020-07-24 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
130,000 | $1.89 | 328,495 (Direct) |
View |
| 2020-07-20 Exercise |
2020-07-22 4:00 pm |
N/A 2029-03-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
188 | $0 | 439,580 (Direct) |
View |
| 2020-07-20 Exercise |
2020-07-22 4:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
188 | $25.4 | 439,580 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 4:00 pm |
N/A 2030-07-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
723 | $34.58 | 723 (Direct) |
View |